- Home
- CPRX vs AVNT Comparison
CPRX vs AVNT Comparison
Compare CPRX & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | AVNT |
|---|---|---|
| Founded | 2002 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 2006 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CPRX | AVNT |
|---|---|---|
| Price | $31.28 | $34.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $35.00 | ★ $41.50 |
| AVG Volume (30 Days) | ★ 2.3M | 675.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | ★ 28.24 | N/A |
| EPS | 0.50 | ★ 0.61 |
| Revenue | $119,072,803.00 | ★ $3,835,500,000.00 |
| Revenue This Year | $9.20 | $4.90 |
| Revenue Next Year | $10.51 | $3.48 |
| P/E Ratio | $62.54 | ★ $55.64 |
| Revenue Growth | ★ 16.39 | 1.71 |
| 52 Week Low | $19.05 | $27.48 |
| 52 Week High | $32.56 | $44.85 |
Technical Indicators
Market Signals| Indicator | CPRX | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 72.04 | 45.84 |
| Support Level | $31.00 | $31.89 |
| Resistance Level | $31.33 | $37.74 |
| Average True Range (ATR) | 0.07 | 1.05 |
| MACD | -0.20 | 0.00 |
| Stochastic Oscillator | 77.78 | 50.68 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.